Monte Rosa Therapeutics | 8-K: Current report
16:09 ET
Monte Rosa Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
May 1 16:30 ET
Monte Rosa Therapeutics | DEFA14A: Others
Apr 26 16:44 ET
Monte Rosa Therapeutics | ARS: Annual Report to Security Holders
Apr 26 16:34 ET
Monte Rosa Therapeutics | DEF 14A: Definitive information statements
Apr 26 16:05 ET
Monte Rosa Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 10 16:29 ET
Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(10.2%)
Apr 10 13:02 ET
Monte Rosa Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 14 16:11 ET
Monte Rosa Therapeutics | 10-K: Annual report
Mar 14 07:48 ET
Monte Rosa Therapeutics | 8-K: Monte Rosa Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Mar 14 07:08 ET
Monte Rosa Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Baker Bros. Advisors LP(9.8%),Baker Bros. Advisors (GP) LLC(9.8%), etc.
Feb 14 17:46 ET
Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Global Healthcare Master Fund, LP(0.00%),Cormorant Global Healthcare GP, LLC(0.00%), etc.
Feb 14 15:09 ET
Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.7%)
Feb 14 11:27 ET
Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(9.9%)
Feb 14 10:20 ET
Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(9.1%),Behzad Aghazadeh(9.1%)
Feb 14 09:17 ET
Monte Rosa Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(11.056%),Abigail P. Johnson(11.056%)
Feb 9 09:30 ET
Monte Rosa Therapeutics | 8-K: Current report
Jan 8 00:00 ET
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dunn Edmund
Jan 4 00:00 ET
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wallace Owen B.
Jan 4 00:00 ET
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Warmuth Markus
Jan 4 00:00 ET
No Data
No Data